Drug · DIN 02562405
HYPERRHO
ALSO KNOWN AS RHO D IMMUNE GLOBULIN HUMAN. SINGLE-USE PREFILLED SYRINGE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since October 27, 2025.
- Drug Identification Number (DIN)
- 02562405
- Company (DIN owner)
- Grifols Therapeutics LlcClayton, North Carolina, United States
- Schedule
- Schedule D
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Immunoglobulins, normal human, for extravasc. adm J06BA01
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANTI-D (RH) IMMUNOGLOBULIN (HUMAN) | 250 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 27, 2025: NOC 36263Supplement to a New Drug Submission (SNDS) · Revised brand name. Alternate drug substance manufacturing facility. Drug substance manufacturing process change. New strength
Other DINs named HYPERRHO
- DIN 02379457 · Approved